Medicare Procedure and Patient Information
2015 Medicare Procedure Volume
Volume of procedures performed by Dr. Steven M. Lipkin, MD, PhD for Medicare patients.
| doctor visit | 13 |
|---|
Loading Page
Dr. Steven M. Lipkin, MD, PhD is a genetics specialist in New York, NY specializing in genetics and physician. He graduated from Duke University School of Medicine. Dr. Steven M. Lipkin, MD, PhD is affiliated with NewYork-Presbyterian and Gastroenterology and Hepatology at David H. Koch Center.
Volume of procedures performed by Dr. Steven M. Lipkin, MD, PhD for Medicare patients.
| doctor visit | 13 |
|---|
Volume of procedures performed by Dr. Steven M. Lipkin, MD, PhD for Medicare patients.
| doctor visit | 13 |
|---|
The top procedures that Dr. Steven M. Lipkin, MD, PhD treated as a genetics specialist in New York, NY during 2017 were blood draw.
Volume of procedures performed by Dr. Steven M. Lipkin, MD, PhD for Medicare patients.
| blood draw | 11 |
|---|---|
| doctor visit | 21 |
| Hypertension | |
|---|---|
| High Cholesterol | |
| Stroke | |
| Ischemic Heart Disease | |
| Depression | |
| Chronic Kidney Disease | |
| Asthma | |
| Osteoperosis | |
| Atrial Fibrilation | |
| Heart Failure | |
| Chronic Obstructive Pulmonary Disease | |
| Diabetes | |
| Dementia | |
| Cancer |
Volume of procedures performed by Dr. Steven M. Lipkin, MD, PhD for Medicare patients.
| doctor visit | 16 |
|---|
Volume of procedures performed by Dr. Steven M. Lipkin, MD, PhD for Medicare patients.
The highest averages for the top procedures that Dr. Steven M. Lipkin, MD, PhD treated as a genetics specialist in New York, NY were blood draw.
| blood draw | 11 |
|---|---|
| doctor visit | 15 |
The highest averages of the most common conditions of Medicare patients that Dr. Steven M. Lipkin, MD, PhD treated were high cholesterol and hypertension.
| Hypertension | |
|---|---|
| High Cholesterol | |
| Stroke | |
| Ischemic Heart Disease | |
| Depression | |
| Chronic Kidney Disease | |
| Asthma | |
| Osteoporosis | |
| Heart Failure | |
| Chronic Obstructive Pulmonary Disease | |
| Diabetes | |
| Atrial Fibrillation | |
| Dementia | |
| Cancer |
Dr. Steven M. Lipkin, MD, PhD graduated from Duke University School of Medicine. He completed residency at Duke University Medical Center. He is certified by the Board Certification: clinical genetics and genomics (md) and has a state license in California.
Medical School: Duke University School of Medicine
Residency: Duke University Medical Center
Board Certification: Board Certification: clinical genetics and genomics (md)
Licensed In: California
Dr. Steven M. Lipkin, MD, PhD does not have any reviews yet, be the first to leave a review of Dr. Steven M. Lipkin, MD, PhD here: Leave a Review
These charts describe general payments received by Dr. Steven M. Lipkin, MD, PhD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$750
$750 |
|
|
$141
$141 |
|
|
$128
$128 |
| $750 | |
| $269 |
Dr. Steven M. Lipkin, MD, PhD has received 5 research payments totaling $207,159.
GENETIC TESTING, WELLNESS WHOLE EXOME AND GENOME SEQUENCING, EXECUTIVE MEDICINE, ADULT GENETIC DISEASES INCLUDING LYNCH SYNDROME/HNPCC, FAMILIAL ADENOMATOUS POLYPOSIS, HEREDITARY BREAST AND PANCREATIC CANNCER, LI-FRAUMENI, JUVENILE POLYPOSIS, PEUTZ-JEGHERS SYNDROME AND OTHER DISORDERSDr. Lipkin is a board certified Medical Geneticist with a focus on genetic testing for adult and cancer genetic diseases, including the Lynch Syndrome, Familial Adenomatous Polyposis, and Hereditary Pancreatic Cancer among others. He is an authority on cancer and adult genetic syndromes, with a particular emphasis on hereditary Gastrointestinal cancer syndromes. He is the author of MAPP-MMR, a bioinformatic program that is used to interpret whether Lynch syndrome missense variants are deleterious mutations or benign polymorphisms. He practices at Weill Medical College of Cornell University and New York-Presbyterian Hospital. He trained in Internal Medicine at Duke University and Medical Genetics at the National Human Genome Research Institute.